{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T13:16:21Z","timestamp":1773926181364,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1-3","license":[{"start":{"date-parts":[[2009,9,2]],"date-time":"2009-09-02T00:00:00Z","timestamp":1251849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biol Trace Elem Res"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s12011-009-8498-3","type":"journal-article","created":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T10:48:19Z","timestamp":1251802099000},"page":"98-111","source":"Crossref","is-referenced-by-count":17,"title":["The Ruthenium Complex cis-(Dichloro)tetraammineruthenium(III) Chloride Presents Selective Cytotoxicity Against Murine B Cell Lymphoma (A-20), Murine Ascitic Sarcoma 180 (S-180), Human Breast Adenocarcinoma (SK-BR-3), and Human T Cell Leukemia (Jurkat) Tumor Cell Lines"],"prefix":"10.1007","volume":"135","author":[{"given":"Elis\u00e2ngela de Paula","family":"Silveira-Lacerda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar Augusto Sam Tiago","family":"Vilanova-Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Am\u00e9lia","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Alfredo","family":"Pavanin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Ricardo","family":"Goulart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria In\u00eas","family":"Homsi-Brandenburgo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wagner Batista","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreimar Martins","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Auro","family":"Nomizo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,9,2]]},"reference":[{"key":"8498_CR1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1040-8428(01)00222-0","volume":"42","author":"N Katsaros","year":"2002","unstructured":"Katsaros N, Anagnostopoulou A (2002) Rhodium and its compounds as potential agents in cancer treatment. Crit Rev Oncol Hematol 42:297\u2013308","journal-title":"Crit Rev Oncol Hematol"},{"key":"8498_CR2","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.2174\/1381612033454180","volume":"9","author":"M Galanski","year":"2003","unstructured":"Galanski M, Arion VB, Jakupec MA, Keppler BK (2003) Recent developments in the field of tumor-inhibiting metal complexes. Curr Pharm Des 9:2078\u20132089","journal-title":"Curr Pharm Des"},{"key":"8498_CR3","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/S0959-8049(98)00224-X","volume":"34","author":"D Lebwohl","year":"1998","unstructured":"Lebwohl D, Canetta R (1998) Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur J Cancer 34:1522\u20131534","journal-title":"Eur J Cancer"},{"key":"8498_CR4","first-page":"1529","volume":"24","author":"B Desoize","year":"2004","unstructured":"Desoize B (2004) Metals and metal compounds in cancer treatment. Anticancer Res 24:1529\u20131544","journal-title":"Anticancer Res"},{"key":"8498_CR5","first-page":"727","volume":"32","author":"MJ Clarke","year":"1996","unstructured":"Clarke MJ, Stubbs M (1996) Interactions of metallopharmaceuticals with DNA. Met Ions Biol Syst 32:727\u2013780","journal-title":"Met Ions Biol Syst"},{"key":"8498_CR6","first-page":"353","volume":"17","author":"G Sava","year":"2000","unstructured":"Sava G, Bergamo A (2000) Ruthenium-based compounds and tumour growth control (review). Int J Oncol 17:353\u2013365","journal-title":"Int J Oncol"},{"key":"8498_CR7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1367-5931(03)00081-4","volume":"7","author":"CX Zhang","year":"2003","unstructured":"Zhang CX, Lippard SJ (2003) New metal complexes as potential therapeutics. Curr Opin Chem Biol 7:481\u2013489","journal-title":"Curr Opin Chem Biol"},{"key":"8498_CR8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1201\/b12414-10","volume":"42","author":"E Alessio","year":"2004","unstructured":"Alessio E, Mestroni G, Bergamo A, Sava G (2004) Ruthenium anticancer drugs. Met Ions Biol Syst 42:323\u2013351","journal-title":"Met Ions Biol Syst"},{"key":"8498_CR9","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0277-5379(84)90223-2","volume":"20","author":"G Sava","year":"1984","unstructured":"Sava G, Zorzet S, Giraldi T, Mestroni G, Zassinovich G (1984) Antineoplastic activity and toxicity of an organometallic complex of ruthenium(II) in comparison with cis-PDD in mice bearing solid malignant neoplasms. Eur J Cancer Clin Oncol 20:841\u2013847","journal-title":"Eur J Cancer Clin Oncol"},{"key":"8498_CR10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00001813-199012000-00001","volume":"1","author":"G Sava","year":"1990","unstructured":"Sava G, Pacor S, Bregant F, Ceschia V, Mestroni G (1990) Metal complexes of ruthenium: antineoplastic properties and perspectives. Anticancer Drugs 1:99\u2013108","journal-title":"Anticancer Drugs"},{"key":"8498_CR11","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.2174\/1568026043387421","volume":"4","author":"E Alessio","year":"2004","unstructured":"Alessio E, Mestroni G, Bergamo A, Sava G (2004) Ruthenium antimetastatic agents. Curr Top Med Chem 4:1525\u20131535","journal-title":"Curr Top Med Chem"},{"key":"8498_CR12","first-page":"761","volume":"9","author":"MR Berger","year":"1989","unstructured":"Berger MR, Garzon FT, Keppler BK, Schmahl D (1989) Efficacy of new ruthenium complexes against chemically induced autochthonous colorectal carcinoma in rats. Anticancer Res 9:761\u2013765","journal-title":"Anticancer Res"},{"key":"8498_CR13","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1432-1033.1995.tb20301.x","volume":"228","author":"O Novakova","year":"1995","unstructured":"Novakova O, Vrana O, Kiseleva VI, Brabec V (1995) DNA interactions of antitumor platinum(IV) complexes. Eur J Biochem 228:616\u2013624","journal-title":"Eur J Biochem"},{"key":"8498_CR14","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/1043-6618(89)90204-1","volume":"21","author":"G Sava","year":"1989","unstructured":"Sava G, Pacor S, Zorzet S, Alessio E, Mestroni G (1989) Antitumour properties of dimethylsulphoxide ruthenium (II) complexes in the Lewis lung carcinoma system. Pharmacol Res 21:617\u2013628","journal-title":"Pharmacol Res"},{"key":"8498_CR15","first-page":"320","volume":"12","author":"LJ Anghileri","year":"1975","unstructured":"Anghileri LJ (1975) Tumor growth inhibition by ammonium chloride-induced acidosis. Int J Clin Pharmacol Biopharm 12:320\u2013326","journal-title":"Int J Clin Pharmacol Biopharm"},{"key":"8498_CR16","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0022-3565(24)38169-8","volume":"289","author":"A Bergamo","year":"1999","unstructured":"Bergamo A, Gagliardi R, Scarcia V, Furlani A, Alessio E, Mestroni G, Sava G (1999) In vitro cell cycle arrest, in vivo action on solid metastasizing tumors, and host toxicity of the antimetastatic drug NAMI-A and cisplatin. J Pharmacol Exp Ther 289:559\u2013564","journal-title":"J Pharmacol Exp Ther"},{"key":"8498_CR17","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1158\/1078-0432.CCR-03-0746","volume":"10","author":"JM Rademaker-Lakhai","year":"2004","unstructured":"Rademaker-Lakhai JM, van den Bongard D, Pluim D, Beijnen JH, Schellens JH (2004) A phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent. Clin Cancer Res 10:3717\u20133727","journal-title":"Clin Cancer Res"},{"key":"8498_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0079-6603(02)71040-4","volume":"71","author":"V Brabec","year":"2002","unstructured":"Brabec V (2002) DNA modifications by antitumor platinum and ruthenium compounds: their recognition and repair. Prog Nucleic Acid Res Mol Biol 71:1\u201368","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"8498_CR19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2174\/1568011053174873","volume":"5","author":"G Zhao","year":"2005","unstructured":"Zhao G, Lin H (2005) Metal complexes with aromatic N-containing ligands as potential agents in cancer treatment. Curr Med Chem Anti-Cancer Agents 5:137\u2013147","journal-title":"Curr Med Chem Anti-Cancer Agents"},{"key":"8498_CR20","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jinorgbio.2004.02.015","volume":"98","author":"M Ravera","year":"2004","unstructured":"Ravera M, Baracco S, Cassino C, Colangelo D, Bagni G, Sava G, Osella D (2004) Electrochemical measurements confirm the preferential bonding of the antimetastatic complex [ImH][RuCl(4)(DMSO)(Im)] (NAMI-A) with proteins and the weak interaction with nucleobases. J Inorg Biochem 98:984\u2013990","journal-title":"J Inorg Biochem"},{"key":"8498_CR21","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1751-1097.1989.tb08423.x","volume":"49","author":"AB Tossi","year":"1989","unstructured":"Tossi AB, Kelly JM (1989) A study of some polypyridylruthenium(II) complexes as DNA binders and photocleavage reagents. Photochem Photobiol 49:545\u2013556","journal-title":"Photochem Photobiol"},{"key":"8498_CR22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/abbi.1999.1654","volume":"376","author":"E Gallori","year":"2000","unstructured":"Gallori E, Vettori C, Alessio E, Vilchez FG, Vilaplana R, Orioli P, Casini A, Messori L (2000) DNA as a possible target for antitumor ruthenium(III) complexes. Arch Biochem Biophys 376:156\u2013162","journal-title":"Arch Biochem Biophys"},{"key":"8498_CR23","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1021\/ic950743z","volume":"35","author":"TK Schoch","year":"1996","unstructured":"Schoch TK, Hubbard JL, Zoch CR, Yi GB, Sorlie M (1996) Synthesis and structure of the ruthenium(ii) complexes [(eta-C5Me5)Ru(NO)(bipy)]2+ and [(eta-C5Me5)Ru(NO)(dppz)]2+. DNA cleavage by an organometallic dppz complex (bipy\u2009=\u20092, 2\u2032-dipyridine; dppz\u2009=\u2009dipyrido[3, 2-a:2\u2032, 3\u2032-c]phenazine). Inorg Chem 35:4383\u20134390","journal-title":"Inorg Chem"},{"key":"8498_CR24","doi-asserted-by":"crossref","first-page":"12369","DOI":"10.1021\/bi00038a034","volume":"34","author":"O Novakova","year":"1995","unstructured":"Novakova O, Kasparkova J, Vrana O, van Vliet PM, Reedijk J, Brabec V (1995) Correlation between cytotoxicity and DNA binding of polypyridyl ruthenium complexes. Biochemistry 34:12369\u201312378","journal-title":"Biochemistry"},{"key":"8498_CR25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00280-004-0773-6","volume":"54","author":"D Pluim","year":"2004","unstructured":"Pluim D, van Waardenburg RC, Beijnen JH, Schellens JH (2004) Cytotoxicity of the organic ruthenium anticancer drug Nami-A is correlated with DNA binding in four different human tumor cell lines. Cancer Chemother Pharmacol 54:71\u201378","journal-title":"Cancer Chemother Pharmacol"},{"key":"8498_CR26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1023\/B:JOPC.0000027852.92208.60","volume":"23","author":"PG Roberto","year":"2004","unstructured":"Roberto PG, Kashima S, Marcussi S, Pereira JO, Astolfi-Filho S, Nomizo A, Giglio JR, Fontes MR, Soares AM, Franca SC (2004) Cloning and identification of a complete cDNA coding for a bactericidal and antitumoral acidic phospholipase A2 from Bothrops jararacussu venom. Protein J 23:273\u2013285","journal-title":"Protein J"},{"key":"8498_CR27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0162-0134(00)00180-X","volume":"83","author":"CR Frasca","year":"2001","unstructured":"Frasca CR, Gehrig LE, Clarke MJ (2001) Cellular effects of transferrin coordinated to [Cl(NH3)5Ru]Cl2 and cis-[Cl2(NH3)4Ru]Cl. J Inorg Biochem 83:139\u2013149","journal-title":"J Inorg Biochem"},{"key":"8498_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0009-2797(83)90037-6","volume":"45","author":"G Sava","year":"1983","unstructured":"Sava G, Giraldi T, Mestroni G, Zassinovich G (1983) Antitumor effects of rhodium(I), iridium(I) and ruthenium(II) complexes in comparison with cis-dichlorodiammino platinum(II) in mice bearing Lewis lung carcinoma. Chem-Biol Interact 45:1\u20136","journal-title":"Chem-Biol Interact"},{"key":"8498_CR29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF01753975","volume":"12","author":"R Gagliardi","year":"1994","unstructured":"Gagliardi R, Sava G, Pacor S, Mestroni G, Alessio E (1994) Antimetastatic action and toxicity on healthy tissues of Na[trans-RuCl4(DMSO)Im] in the mouse. Clin Exp Metastasis 12:93\u2013100","journal-title":"Clin Exp Metastasis"},{"key":"8498_CR30","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1016\/S0021-9258(17)41984-3","volume":"269","author":"F Kratz","year":"1994","unstructured":"Kratz F, Hartmann M, Keppler B, Messori L (1994) The binding properties of two antitumor ruthenium(III) complexes to apotransferrin. J Biol Chem 269:2581\u20132588","journal-title":"J Biol Chem"},{"key":"8498_CR31","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF02890388","volume":"42","author":"J Alroy","year":"1983","unstructured":"Alroy J, Goyal V, Ucci AA, Klauber GT, Heaney JA, Cohen SM (1983) Cell surface coat of human and rat bladder urothelium. I. Ruthenium-red studies in non-neoplastic and neoplastic cells. Virchows Arch B Cell Pathol Incl Mol Pathol 42:251\u2013262","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"key":"8498_CR32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0883-2897(89)90107-4","volume":"16","author":"I Zanzi","year":"1989","unstructured":"Zanzi I, Srivastava SC, Meinken GE, Robeson W, Mausner LF, Fairchild RG, Margouleff D (1989) A new cholescintigraphic agent: ruthenium-97-DISIDA. Int J Rad Appl Instrum B 16:397\u2013403","journal-title":"Int J Rad Appl Instrum B"},{"key":"8498_CR33","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/j.jinorgbio.2004.10.007","volume":"98","author":"V Djinovi\u0107","year":"2004","unstructured":"Djinovi\u0107 V, Mom\u010dilovi\u0107 M, Grguri\u0107-\u0160ipka S, Trajkovi\u0107 V, Stojkovi\u0107 M, Miljkovi\u0107 D, Sabo T (2004) Novel ruthenium complex K2[Ru(dmgly)Cl4].2H2O is toxic to C6 astrocytoma cell line, but not to primary rat astrocytes. J Inorg Biochem 98:2168\u20132173","journal-title":"J Inorg Biochem"},{"key":"8498_CR34","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0022-3565(24)38990-6","volume":"295","author":"S Zorzet","year":"2000","unstructured":"Zorzet S, Bergamo A, Cocchietto M, Sorc A, Gava B, Alessio E, Iengo E, Sava G (2000) Lack of in vitro cytotoxicity, associated to increased G(2)-M cell fraction and inhibition of matrigel invasion, may predict In vivo-selective antimetastasis activity of ruthenium complexes. J Pharmacol Exp Ther 295:927\u2013933","journal-title":"J Pharmacol Exp Ther"},{"key":"8498_CR35","first-page":"213","volume":"83","author":"LJ Anghileri","year":"1975","unstructured":"Anghileri LJ (1975) The in vivo inhibition of tumor growth by ruthenium red: its relationship with the metabolism of calcium in the tumor. Cancer Res Clin Oncol 83:213\u2013217","journal-title":"Cancer Res Clin Oncol"},{"key":"8498_CR36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0009-2797(94)03350-1","volume":"95","author":"G Sava","year":"1995","unstructured":"Sava G, Pacor S, Bergamo A, Cocchietto M, Mestroni G, Alessio E (1995) Effects of ruthenium complexes on experimental tumors: irrelevance of cytotoxicity for metastasis inhibition. Chem-Biol Interact 95:109\u2013126","journal-title":"Chem-Biol Interact"},{"key":"8498_CR37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00432-004-0617-0","volume":"131","author":"S Kapitza","year":"2005","unstructured":"Kapitza S, Pongratz M, Jakupec MA, Heffeter P, Berger W, Lackinger L, Keppler BK, Marian B (2005) Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells. J Cancer Res Clin Oncol 131:101\u2013110","journal-title":"J Cancer Res Clin Oncol"},{"key":"8498_CR38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0962-8924(00)88932-1","volume":"5","author":"CD Bortner","year":"1995","unstructured":"Bortner CD, Oldenburg NB, Cidlowski JA (1995) The role of DNA fragmentation in apoptosis. Trends Cell Biol 5:21\u201326","journal-title":"Trends Cell Biol"},{"key":"8498_CR39","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1038\/sj.onc.1202581","volume":"17","author":"G Nunez","year":"1998","unstructured":"Nunez G, Benedict MA, Hu Y, Inohara N (1998) Caspases: the proteases of the apoptotic pathway. Oncogene 17:3237\u20133245","journal-title":"Oncogene"},{"key":"8498_CR40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0167-5699(94)90018-3","volume":"15","author":"TM Buttke","year":"1994","unstructured":"Buttke TM, Sandstrom PA (1994) Oxidative stress as a mediator of apoptosis. Immunol Today 15:7\u201310","journal-title":"Immunol Today"},{"key":"8498_CR41","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1073\/pnas.83.13.4646","volume":"83","author":"TC Bruice","year":"1986","unstructured":"Bruice TC, Zipplies MF, Lee WA (1986) The pH dependence of the mechanism of reaction of hydrogen peroxide with a nonaggregating, non-mu-oxo dimer-forming iron (III) porphyrin in water. Proc Natl Acad Sci U S A 83:4646\u20134649","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8498_CR42","doi-asserted-by":"crossref","first-page":"8523","DOI":"10.1021\/ja991113p","volume":"121","author":"R Dominic","year":"1999","unstructured":"Dominic R, Frasca DR, Clarke MJ (1999) Alterations in the binding of [Cl(NH3)5RuIII]2+ to DNA by glutathione: reduction, autoxidation, coordination, and decomposition. J Am Chem Soc 121:8523\u20138532","journal-title":"J Am Chem Soc"},{"key":"8498_CR43","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0162-0134(96)00091-8","volume":"65","author":"S Choua","year":"1997","unstructured":"Choua S, Pacheco P, Coquelet C, Bienven\u00fce E (1997) Catalase-like activity of water soluble complex of Ru(II). J Inorg Biochem 65:79\u201385","journal-title":"J Inorg Biochem"},{"key":"8498_CR44","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.cbi.2007.02.003","volume":"167","author":"CSR Menezes","year":"2007","unstructured":"Menezes CSR, Gebrim LC, \u00c1vila VMR, Ferreira MJ, Vieira CU, Pavanin LA, Homsi-Brandeburgo MI, Hamaguchi A, Silveira-Lacerda EP (2007) Analysis in vivo of antitumor activity, cytotoxicity and interaction between plasmid DNA and the cis-dichlorotetraammineruthenium(III) chloride. Chem-Biol Interact 167:116\u2013124","journal-title":"Chem-Biol Interact"},{"key":"8498_CR45","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1002\/eji.1830221222","volume":"22","author":"J Mengel","year":"1992","unstructured":"Mengel J, Dare L, Dare GM, Delgado M, Nomizo A, Silva JS, Campos-Neto A (1992) An activated murine B cell lymphoma line (A-20) produces a factor-like activity which is functionally related to human natural killer cell stimulatory factor. Eur J Immunol 22:3173\u20133178","journal-title":"Eur J Immunol"},{"key":"8498_CR46","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1124\/jpet.104.066175","volume":"310","author":"S Pacor","year":"2004","unstructured":"Pacor S, Zorzet S, Cocchietto M, Bacac M, Vadori M, Turrin C, Gava B, Castellarin A, Sava G (2004) Intratumoral NAMI-A treatment triggers metastasis reduction, which correlates to CD44 regulation and tumor infiltrating lymphocyte recruitment. J Pharmacol Exp Ther 310:737\u2013744","journal-title":"J Pharmacol Exp Ther"},{"key":"8498_CR47","author":"ASBB Ribeiro","year":"2009","unstructured":"Ribeiro ASBB, da Silva CC, Pereira FC, Lima AP, Vilanova-Costa CAST, Aguiar SS, Pavanin LA, da Cruz AD, Silveira-Lacerda EP (2009) Mutagenic and genotoxic effects of cis-(dichloro)tetraammineruthenium(III) chloride on human peripheral blood lymphocytes. Biol Trace Elem Res. doi: 10.1007\/s12011-009-8334-9","journal-title":"Biol Trace Elem Res"},{"key":"8498_CR48","author":"EP Silveira-Lacerda","year":"2009","unstructured":"Silveira-Lacerda EP, Vilanova-Costa CAST, Pereira FC, Hamaguchi A, Pavanin LA, Goulart LR, Homsi-Brandenburgo MI, Soares AM, dos Santos WB, Nomizo A (2009) The ruthenium complex cis-(dichloro)tetraammineruthenium(III) chloride presents immune stimulatory activity on human peripheral blood mononuclear cells. Biol Trace Elem Res. doi: 10.1007\/s12011-009-8440-8","journal-title":"Biol Trace Elem Res"},{"key":"8498_CR49","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.drudis.2009.02.002","volume":"14","author":"A Alama","year":"2009","unstructured":"Alama A, Tasso B, Novelli F, Sparatore F (2009) Organometallic compounds in oncology: implications of novel organotins as antitumor agents. Drug Discov Today 14:500\u2013508","journal-title":"Drug Discov Today"},{"key":"8498_CR50","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2174\/092986706776360941","volume":"13","author":"J Kostova","year":"2006","unstructured":"Kostova J (2006) Ruthenium complexes as anticancer agents. Curr Med Chem 13:1085\u20131107","journal-title":"Curr Med Chem"},{"key":"8498_CR51","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0003-9861(02)00218-7","volume":"403","author":"B Sanna","year":"2002","unstructured":"Sanna B, Debidda M, Pintus G, Tadolini B, Posadino AM, Bennardini F, Sava G, Ventura C (2002) The anti-metastatic agent imidazolium trans-imidazoledimethylsulfoxide-tetrachlororuthenate induces endothelial cell apoptosis by inhibiting the mitogen-activated protein kinase\/extracellular signal-regulated kinase signaling pathway. Arch Biochem Biophys 403:209\u2013218","journal-title":"Arch Biochem Biophys"},{"key":"8498_CR52","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jinorgbio.2006.02.013","volume":"100","author":"CG Hartinger","year":"2006","unstructured":"Hartinger CG, Zorbas-Seifried S, Jakupec MA, Kynast B, Zorbas H, Keppler BK (2006) From bench to bedside\u2014preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachloro bis(1Hindazole) ruthenate(III)] (KP1019 or FFC144). J Inorg Biochem 100:891\u2013904","journal-title":"J Inorg Biochem"},{"key":"8498_CR53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0010-8545(02)00312-0","volume":"236","author":"MJ Clarke","year":"2003","unstructured":"Clarke MJ (2003) Ruthenium metallopharmaceuticals. Coord Chem Rev 236:209\u2013233","journal-title":"Coord Chem Rev"}],"container-title":["Biological Trace Element Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-009-8498-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12011-009-8498-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-009-8498-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T23:03:29Z","timestamp":1739315009000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12011-009-8498-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,2]]},"references-count":53,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["8498"],"URL":"https:\/\/doi.org\/10.1007\/s12011-009-8498-3","relation":{},"ISSN":["0163-4984","1559-0720"],"issn-type":[{"value":"0163-4984","type":"print"},{"value":"1559-0720","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,2]]}}}